Dhanvantri Jeevan Rekha Ltd

Dhanvantri Jeevan Rekha has announced its financial results for the quarter ending December 2024, showcasing stable performance. The company reported a Profit After Tax of Rs 0.32 crore for the half-year, exceeding last year's figures, and achieved its highest quarterly net sales in five quarters at Rs 5.70 crore.

Dhanvantri Jeevan Rekha, a microcap company in the hospital and healthcare services industry, reported a flat performance for the quarter ending September 2024 with a score of 4 out of 10. However, its Profit After Tax for the half-yearly period has shown significant growth, surpassing the previous 12-month period in just six months. The company also recorded its highest Operating Cash Flow in the last three years, indicating financial stability and potential for growth.

Dhanvantri Jeevan Rekha, a microcap healthcare services company, has reported a flat performance for the quarter ended June 2024. However, the company has shown growth in profits and revenue in the nine-month period. Despite this, stock analysis platform MarketsMOJO has a 'Sell' call for the company's stock. Investors should carefully evaluate all factors before investing.

Dhanvantri Jeevan Rekha, a microcap healthcare services company, has reported a flat financial performance in the quarter ended March 2024, with a score of 2 out of 10. However, the company's Profit After Tax has shown a significant improvement, while its Operating Profit has decreased. MarketsMOJO has given a 'Sell' call for the company's stock.

Dhanvantri Jeevan Rekha, a microcap healthcare services company, has seen a surge in its stock price, reaching a 52-week high and outperforming its sector by 2.74%. With a 'Hold' call from MarketsMOJO and trading above its moving averages, the company has shown strong potential and growth in the past year.

Dhanvantri Jeevan Rekha, a microcap healthcare services company, has seen a significant increase in its stock price, reaching a 52-week high on February 29, 2024. The stock has been performing well in the market, with a 32.51% increase in returns over the past nine days and trading higher than its moving averages. Despite its small size, the company has attracted investors and shown strong growth in the past year.

Dhanvantri Jeevan Rekha, a microcap healthcare services company, has seen a significant increase in its stock price, reaching a 52-week high on February 28th, 2024. The stock has been performing well in the market, with a 'Hold' call from MarketsMOJO and outperforming the sector by 2.52%. Despite its small size, the company has shown strong growth and potential in the past year, making it a company to watch in the healthcare services industry.

Dhanvantri Jeevan Rekha, a microcap healthcare services company, has seen a surge in its stock price, reaching a 52-week high and consistently outperforming the sector. According to MarketsMOJO, the current call for the stock is 'Hold' and it has been trading above its moving averages. With a 92.85% increase in the past year, the company shows potential for growth in the healthcare industry.

Dhanvantri Jeevan Rekha, a microcap healthcare services company, has seen a significant increase in its stock price, reaching a 52-week high on February 26th, 2024. The company has shown consistent growth and outperformed the sector, with a strong performance in the past year. Despite its small size, Dhanvantri Jeevan Rekha has caught the attention of investors and has potential for further success in the healthcare industry.

Dhanvantri Jeevan Rekha, a microcap healthcare services company, has seen a surge in its stock price, reaching a 52-week high on February 23, 2024. The stock has consistently outperformed the sector and is currently trading above its moving averages, indicating a positive trend. With a remarkable growth of 85.40% in the past year, the company shows potential for growth in the healthcare industry.

Dhanvantri Jeevan Rekha, a microcap healthcare services company, has reached a 52-week high on February 22, 2024, with a current stock price of Rs.24.65. The stock has been consistently gaining for the past four days and has outperformed the sector by 4.27% today. With a strong performance of 77.34% in the past year, the company shows potential for growth in the healthcare services industry. Investors may consider holding onto their stocks, but should always do thorough research and seek professional advice before making any investment decisions.

Dhanvantri Jeevan Rekha, a microcap healthcare services company, has hit a 52-week high on February 21, 2024. The stock has been performing well, with a 4.96% gain on the day of the high. It has also outperformed the sector by 5.06% and is currently trading higher than its moving averages, indicating a positive trend. In the past year, the stock has shown a strong performance and has gained 68.92%, showcasing its growth potential in the industry. With a 'Hold' call from MarketsMOJO, investors can consider holding onto their investments in this company.

Dhanvantri Jeevan Rekha, a microcap healthcare services company, reached a new 52-week high on February 5th, 2024. Despite a recent dip, the stock is still trading higher than its moving averages and has shown strong performance in the past year, outperforming the Sensex. Investors should monitor the company's progress.

Dhanvantri Jeevan Rekha, a microcap healthcare services company, has seen a surge in its stock price, reaching a 52-week high of Rs.21 on February 2, 2024. Despite a 'Sell' rating from MarketsMOJO, the stock has outperformed the sector and the Sensex in the past year, indicating strong performance in the healthcare industry. However, the stock's small market capitalization may make it more volatile and risky for investors.

Dhanvantri Jeevan Rekha, a microcap healthcare services company, has seen a surge in its stock price, reaching a 52-week high on February 1st, 2024. The stock has outperformed its sector by 4.43% and gained 10.24% in the last 3 days. Despite a 'Sell' call from MarketsMOJO, the stock has been trading higher than its moving averages, indicating a positive trend. In the past year, the company has shown a strong performance, showcasing its potential for growth and ability to outperform the market.

Dhanvantri Jeevan Rekha, a microcap healthcare services company, has seen a surge in its stock price, reaching a 52-week high on January 24th, 2024. Despite being rated as a 'Sell' by MarketsMOJO, the company has shown a strong performance in the past year, outperforming its sector and consistently trading above its moving averages. Its success can be attributed to its strong business model and efficient management.

Dhanvantri Jeevan Rekha, a microcap healthcare services company, has seen a surge in its stock price, reaching a 52-week high on January 23, 2024. The company has outperformed its sector by 4.29% and gained 20.91% in the last 4 days. Its strong performance and focus on quality healthcare services have attracted investor attention.

Dhanvantri Jeevan Rekha, a microcap healthcare services company, has seen a surge in its stock price, hitting a 52-week high and outperforming the sector by 4.76%. It has also shown consecutive gains for the last 3 days and is currently trading higher than its moving averages. The company has outperformed the Sensex, showcasing its strong growth potential and ability to deliver value to shareholders.

Dhanvantri Jeevan Rekha, a microcap healthcare services company, has seen a surge in its stock price, reaching a 52-week high on January 19, 2024. Despite being rated as a 'Sell' by MarketsMOJO, the company has shown strong performance in the past year, outperforming its sector and consistently trading higher than its moving averages.